A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment
Clinical trial NCT03713957 · COMPLETED
Trial details
- NCT number
- NCT03713957
- Sponsor
- Alkahest, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-12
- Primary completion
- 2020-07-20
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.